Propanc Biopharma, Inc. Common Stock

PPCBNASDAQ • USD
1.89 USD
↘ 0.05 (2.62%)AT CLOSE (03:59 PM EST)
1.85
↘ 0.04 (2.38%)
POST MARKET (AS OF 05:28 PM EST)
Post Market
AS OF 05:28 PM EST
1.85
↘ 0.04 (2.38%)
🟢Market: OPEN

PPCB is currently priced at $1.85. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.88
High?$1.91
Low?$1.75
Prev. Close?$1.94
Volume?8.5K
Avg. Volume?217.8K
VWAP?$1.83
Rel. Volume?0.04x
Bid / Ask
Bid?$1.54 × 100
Ask?$2.22 × 100
Spread?$0.68
Midpoint?$1.88
Valuation & Ratios
Market Cap?1.9M
Shares Out?1.0M
Float?6.9M
Float %?66.9%
P/E Ratio?N/A
P/B Ratio?0.20
EPS?-$20.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Employees
2
Market Cap
1.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2012-06-15
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-19.70Distress
Confidence?23%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.29%Low
Short Interest?19.7K
Days to Cover?1.0
Free Float6.9M
Avg Daily Volume57.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.55Strong
Quick Ratio?2.55Strong
Cash Ratio?0.25Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.20CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-210.6%WEAK▾
ROA?
S&P
3
-154.9%WEAK▾
Cash Flow & Enterprise
FCF?$-5687568
Enterprise Value?$1.1M
Fundamentals ratios updated end of day